Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 19 studies | 36% ± 18% | |
fibroblast | 13 studies | 30% ± 14% | |
smooth muscle cell | 10 studies | 31% ± 10% | |
endothelial cell of lymphatic vessel | 8 studies | 50% ± 17% | |
ciliated cell | 7 studies | 34% ± 18% | |
cardiac muscle cell | 6 studies | 74% ± 17% | |
mesothelial cell | 5 studies | 49% ± 25% | |
glutamatergic neuron | 5 studies | 36% ± 12% | |
myofibroblast cell | 5 studies | 29% ± 15% | |
type I pneumocyte | 5 studies | 55% ± 3% | |
type II pneumocyte | 5 studies | 39% ± 3% | |
basal cell | 5 studies | 39% ± 24% | |
cholangiocyte | 4 studies | 75% ± 12% | |
pericyte | 4 studies | 23% ± 8% | |
GABAergic neuron | 4 studies | 34% ± 13% | |
club cell | 4 studies | 40% ± 14% | |
interneuron | 4 studies | 36% ± 13% | |
epithelial cell | 3 studies | 23% ± 3% | |
luminal hormone-sensing cell of mammary gland | 3 studies | 21% ± 7% | |
endothelial cell of vascular tree | 3 studies | 30% ± 20% | |
hepatocyte | 3 studies | 71% ± 24% | |
connective tissue cell | 3 studies | 36% ± 24% | |
capillary endothelial cell | 3 studies | 60% ± 7% | |
respiratory goblet cell | 3 studies | 38% ± 18% | |
astrocyte | 3 studies | 45% ± 22% | |
abnormal cell | 3 studies | 21% ± 4% | |
mucus secreting cell | 3 studies | 46% ± 26% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 8645.81 | 245 / 245 | 94% | 23.09 | 473 / 502 |
thymus | 99% | 2426.08 | 647 / 653 | 87% | 14.17 | 527 / 605 |
uterus | 100% | 5573.22 | 170 / 170 | 59% | 11.41 | 269 / 459 |
pancreas | 76% | 859.68 | 250 / 328 | 79% | 9.49 | 141 / 178 |
lung | 99% | 2717.33 | 574 / 578 | 51% | 4.59 | 587 / 1155 |
ovary | 59% | 668.63 | 106 / 180 | 90% | 54.52 | 388 / 430 |
breast | 62% | 2369.35 | 285 / 459 | 83% | 36.21 | 927 / 1118 |
stomach | 95% | 2015.64 | 340 / 359 | 44% | 3.50 | 126 / 286 |
esophagus | 73% | 5787.16 | 1057 / 1445 | 63% | 7.92 | 116 / 183 |
kidney | 94% | 2066.85 | 84 / 89 | 40% | 4.74 | 364 / 901 |
adrenal gland | 99% | 2084.65 | 255 / 258 | 35% | 3.14 | 80 / 230 |
bladder | 95% | 3694.14 | 20 / 21 | 38% | 3.02 | 192 / 504 |
skin | 97% | 2128.05 | 1753 / 1809 | 7% | 0.60 | 33 / 472 |
liver | 79% | 815.23 | 178 / 226 | 24% | 3.97 | 98 / 406 |
intestine | 56% | 1022.13 | 538 / 966 | 46% | 3.89 | 242 / 527 |
heart | 97% | 4966.54 | 837 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 86% | 4060.86 | 1153 / 1335 | 0% | 0 | 0 / 0 |
brain | 45% | 462.13 | 1192 / 2642 | 32% | 2.90 | 229 / 705 |
adipose | 39% | 575.44 | 464 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 38% | 3.37 | 17 / 45 |
spleen | 19% | 150.31 | 46 / 241 | 0% | 0 | 0 / 0 |
muscle | 14% | 107.95 | 113 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0048251 | Biological process | elastic fiber assembly |
GO_0030198 | Biological process | extracellular matrix organization |
GO_0160054 | Biological process | microfibril assembly |
GO_0001527 | Cellular component | microfibril |
GO_0070062 | Cellular component | extracellular exosome |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0005201 | Molecular function | extracellular matrix structural constituent |
GO_0016787 | Molecular function | hydrolase activity |
Gene name | THSD4 |
Protein name | Thrombospondin type-1 domain-containing protein 4 (A disintegrin and metalloproteinase with thrombospondin motifs-like protein 6) (ADAMTS-like protein 6) (ADAMTSL-6) Thrombospondin type 1 domain containing 4 |
Synonyms | UNQ9334/PRO34005 |
Description | FUNCTION: Promotes FBN1 matrix assembly. Attenuates TGFB signaling, possibly by accelerating the sequestration of large latent complexes of TGFB or active TGFB by FBN1 microfibril assembly, thereby negatively regulating the expression of TGFB regulatory targets, such as POSTN. . |
Accessions | ENST00000261862.8 [Q6ZMP0-1] ENST00000620694.1 Q6ZMP0 ENST00000357769.4 [Q6ZMP0-4] A0A087X1T0 ENST00000355327.7 [Q6ZMP0-1] |